Annual Operating Expenses
$15.07 M
-$1.20 M-7.39%
December 31, 2023
Summary
- As of February 24, 2025, POAI annual total operating expenses is $15.07 million, with the most recent change of -$1.20 million (-7.39%) on December 31, 2023.
- During the last 3 years, POAI annual operating expenses has risen by +$1.78 million (+13.38%).
- POAI annual operating expenses is now -7.39% below its all-time high of $16.27 million, reached on December 31, 2022.
Performance
POAI Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.46 M
-$852.30 K-25.71%
September 30, 2024
Summary
- As of February 24, 2025, POAI quarterly total operating expenses is $2.46 million, with the most recent change of -$852.30 thousand (-25.71%) on September 30, 2024.
- Over the past year, POAI quarterly operating expenses has stayed the same.
- POAI quarterly operating expenses is now -53.24% below its all-time high of $5.27 million, reached on June 30, 2019.
Performance
POAI Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
POAI Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.4% | 0.0% |
| 3 y3 years | +13.4% | -40.3% |
| 5 y5 years | +70.1% | -40.3% |
POAI Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.4% | +4.6% | -51.0% | at low |
| 5 y | 5-year | -7.4% | +13.4% | -51.0% | at low |
| alltime | all time | -7.4% | +800.4% | -53.2% | +1831.5% |
Predictive Oncology Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.46 M(-25.7%) |
| Jun 2024 | - | $3.31 M(-25.8%) |
| Mar 2024 | - | $4.47 M(-11.2%) |
| Dec 2023 | $15.07 M(-7.4%) | $5.03 M(+51.6%) |
| Sep 2023 | - | $3.32 M(-19.6%) |
| Jun 2023 | - | $4.13 M(+15.1%) |
| Mar 2023 | - | $3.58 M(-22.7%) |
| Dec 2022 | $16.27 M(+12.9%) | $4.64 M(+3.6%) |
| Sep 2022 | - | $4.48 M(+26.8%) |
| Jun 2022 | - | $3.53 M(-2.4%) |
| Mar 2022 | - | $3.62 M(-23.9%) |
| Dec 2021 | $14.41 M(+8.4%) | $4.76 M(+65.0%) |
| Sep 2021 | - | $2.88 M(+2.8%) |
| Jun 2021 | - | $2.81 M(-29.2%) |
| Mar 2021 | - | $3.96 M(+38.3%) |
| Dec 2020 | $13.29 M(-9.3%) | $2.86 M(-1.8%) |
| Sep 2020 | - | $2.92 M(-24.5%) |
| Jun 2020 | - | $3.87 M(+6.2%) |
| Mar 2020 | - | $3.64 M(+17.1%) |
| Dec 2019 | $14.65 M(+65.4%) | $3.11 M(-17.3%) |
| Sep 2019 | - | $3.76 M(-28.6%) |
| Jun 2019 | - | $5.27 M(+109.1%) |
| Mar 2019 | - | $2.52 M(-16.9%) |
| Dec 2018 | $8.86 M(+35.0%) | $3.03 M(+43.9%) |
| Sep 2018 | - | $2.11 M(+26.8%) |
| Jun 2018 | - | $1.66 M(-20.1%) |
| Mar 2018 | - | $2.08 M(+55.7%) |
| Dec 2017 | $6.56 M(-3.5%) | $1.34 M(+19.7%) |
| Sep 2017 | - | $1.12 M(-57.5%) |
| Jun 2017 | - | $2.63 M(+77.6%) |
| Mar 2017 | - | $1.48 M(+76.2%) |
| Dec 2016 | $6.80 M | $839.80 K(-27.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $1.16 M(-55.4%) |
| Jun 2016 | - | $2.61 M(+19.3%) |
| Mar 2016 | - | $2.19 M(-6.7%) |
| Dec 2015 | $4.75 M(-32.5%) | $2.35 M(+107.4%) |
| Sep 2015 | - | $1.13 M(-1.4%) |
| Jun 2015 | - | $1.15 M(+799.3%) |
| Mar 2015 | - | $127.50 K(-94.2%) |
| Dec 2014 | $7.03 M(-23.6%) | $2.20 M(+76.4%) |
| Sep 2014 | - | $1.25 M(-35.8%) |
| Jun 2014 | - | $1.94 M(+17.7%) |
| Mar 2014 | - | $1.65 M(-24.3%) |
| Dec 2013 | $9.21 M(+27.5%) | $2.18 M(-41.4%) |
| Sep 2013 | - | $3.71 M(+209.1%) |
| Jun 2013 | - | $1.20 M(-43.1%) |
| Mar 2013 | - | $2.11 M(+32.7%) |
| Dec 2012 | $7.22 M(+74.1%) | $1.59 M(-43.8%) |
| Sep 2012 | - | $2.83 M(+33.1%) |
| Jun 2012 | - | $2.13 M(+219.0%) |
| Mar 2012 | - | $667.40 K(-74.1%) |
| Dec 2011 | $4.15 M(+76.3%) | $2.58 M(+312.6%) |
| Sep 2011 | - | $625.20 K(+21.0%) |
| Jun 2011 | - | $516.90 K(+21.8%) |
| Mar 2011 | - | $424.30 K(-11.0%) |
| Dec 2010 | $2.35 M(-16.7%) | $477.00 K(+0.8%) |
| Sep 2010 | - | $473.10 K(-14.1%) |
| Jun 2010 | - | $551.00 K(-35.2%) |
| Mar 2010 | - | $849.90 K(+16.0%) |
| Dec 2009 | $2.82 M(+68.6%) | $732.80 K(-10.0%) |
| Sep 2009 | - | $814.30 K(+4.3%) |
| Jun 2009 | - | $780.90 K(+58.0%) |
| Mar 2009 | - | $494.10 K(-32.2%) |
| Dec 2008 | $1.67 M | $729.10 K(+64.4%) |
| Sep 2008 | - | $443.40 K |
FAQ
- What is Predictive Oncology annual total operating expenses?
- What is the all time high annual operating expenses for Predictive Oncology?
- What is Predictive Oncology annual operating expenses year-on-year change?
- What is Predictive Oncology quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Predictive Oncology?
- What is Predictive Oncology quarterly operating expenses year-on-year change?
What is Predictive Oncology annual total operating expenses?
The current annual operating expenses of POAI is $15.07 M
What is the all time high annual operating expenses for Predictive Oncology?
Predictive Oncology all-time high annual total operating expenses is $16.27 M
What is Predictive Oncology annual operating expenses year-on-year change?
Over the past year, POAI annual total operating expenses has changed by -$1.20 M (-7.39%)
What is Predictive Oncology quarterly total operating expenses?
The current quarterly operating expenses of POAI is $2.46 M
What is the all time high quarterly operating expenses for Predictive Oncology?
Predictive Oncology all-time high quarterly total operating expenses is $5.27 M
What is Predictive Oncology quarterly operating expenses year-on-year change?
Over the past year, POAI quarterly total operating expenses has changed by $0.00 (0.00%)